Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients

Nicholas Rowan, Jonas T. Johnson, Christina E. Fratangelo, Brenda K. Smith, Patricia A. Kemerer, Robert L. Ferris

Research output: Contribution to journalArticle

Abstract

Objectives Investigate both the utility and feasibility of perioperative nutritional supplementation with an arginine-enriched immunonutrition formula to high-risk head and neck cancer surgical patients and examine its effects on acute post-operative clinical outcomes. Materials & Methods This prospective, non-randomized, interventional cohort study compared high-risk head and neck cancer surgical patients who consumed a pre- and post-operative arginine-based nutritional supplement to those that did not. Outcome measures included post-operative complications, length of hospitalization, readmission rates and measurement of nutritional biomarkers. Results 195 high-risk head and neck cancer surgical patients were enrolled. 59% of the patients used the nutritional supplement, 41% did not. Of the 80 patients who did not receive the immunonutrition formula, 38 (47.5%) experienced post-operative complications of all types as compared to 29 of the 115 (25.2%) patients who did consume the product (p = 0.0021). Pharyngeal leaks or fistulas were the most common post-operative complications in both groups and more common in patients who did not receive supplementation (p = 0.007). Length of stay was on average 2.8 days longer in patients who did not have enhanced nutrition (p = 0.02), while readmission rates between the two groups were similar (p = 0.91). Measurements of nutritional biomarkers were not reported secondary to low collection rates. Conclusion Enhanced perioperative nutrition may result in significant reductions of post-operative fistula formations and decreased length of stay in a high-risk head and neck cancer population, even in the setting of poor compliance. The potential quality improvement in both patient care and healthcare cost is both real and significant.

Original languageEnglish (US)
Pages (from-to)42-46
Number of pages5
JournalOral Oncology
Volume54
DOIs
StatePublished - Mar 1 2016
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Head
Fistula
Arginine
Length of Stay
Biomarkers
Quality Improvement
Health Care Costs
Patient Care
Hospitalization
Cohort Studies
Outcome Assessment (Health Care)
Population

Keywords

  • Arginine
  • Fistula
  • Head and neck cancer
  • Healthcare costs
  • Laryngeal cancer
  • Length of stay
  • Nutritional status
  • Oral cancer
  • Oropharyngeal cancer
  • Quality improvement

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients. / Rowan, Nicholas; Johnson, Jonas T.; Fratangelo, Christina E.; Smith, Brenda K.; Kemerer, Patricia A.; Ferris, Robert L.

In: Oral Oncology, Vol. 54, 01.03.2016, p. 42-46.

Research output: Contribution to journalArticle

Rowan, Nicholas ; Johnson, Jonas T. ; Fratangelo, Christina E. ; Smith, Brenda K. ; Kemerer, Patricia A. ; Ferris, Robert L. / Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients. In: Oral Oncology. 2016 ; Vol. 54. pp. 42-46.
@article{84d2aaabc0d94c20b44e5b2573297fff,
title = "Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients",
abstract = "Objectives Investigate both the utility and feasibility of perioperative nutritional supplementation with an arginine-enriched immunonutrition formula to high-risk head and neck cancer surgical patients and examine its effects on acute post-operative clinical outcomes. Materials & Methods This prospective, non-randomized, interventional cohort study compared high-risk head and neck cancer surgical patients who consumed a pre- and post-operative arginine-based nutritional supplement to those that did not. Outcome measures included post-operative complications, length of hospitalization, readmission rates and measurement of nutritional biomarkers. Results 195 high-risk head and neck cancer surgical patients were enrolled. 59{\%} of the patients used the nutritional supplement, 41{\%} did not. Of the 80 patients who did not receive the immunonutrition formula, 38 (47.5{\%}) experienced post-operative complications of all types as compared to 29 of the 115 (25.2{\%}) patients who did consume the product (p = 0.0021). Pharyngeal leaks or fistulas were the most common post-operative complications in both groups and more common in patients who did not receive supplementation (p = 0.007). Length of stay was on average 2.8 days longer in patients who did not have enhanced nutrition (p = 0.02), while readmission rates between the two groups were similar (p = 0.91). Measurements of nutritional biomarkers were not reported secondary to low collection rates. Conclusion Enhanced perioperative nutrition may result in significant reductions of post-operative fistula formations and decreased length of stay in a high-risk head and neck cancer population, even in the setting of poor compliance. The potential quality improvement in both patient care and healthcare cost is both real and significant.",
keywords = "Arginine, Fistula, Head and neck cancer, Healthcare costs, Laryngeal cancer, Length of stay, Nutritional status, Oral cancer, Oropharyngeal cancer, Quality improvement",
author = "Nicholas Rowan and Johnson, {Jonas T.} and Fratangelo, {Christina E.} and Smith, {Brenda K.} and Kemerer, {Patricia A.} and Ferris, {Robert L.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.oraloncology.2016.01.006",
language = "English (US)",
volume = "54",
pages = "42--46",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Utility of a perioperative nutritional intervention on postoperative outcomes in high-risk head & neck cancer patients

AU - Rowan, Nicholas

AU - Johnson, Jonas T.

AU - Fratangelo, Christina E.

AU - Smith, Brenda K.

AU - Kemerer, Patricia A.

AU - Ferris, Robert L.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objectives Investigate both the utility and feasibility of perioperative nutritional supplementation with an arginine-enriched immunonutrition formula to high-risk head and neck cancer surgical patients and examine its effects on acute post-operative clinical outcomes. Materials & Methods This prospective, non-randomized, interventional cohort study compared high-risk head and neck cancer surgical patients who consumed a pre- and post-operative arginine-based nutritional supplement to those that did not. Outcome measures included post-operative complications, length of hospitalization, readmission rates and measurement of nutritional biomarkers. Results 195 high-risk head and neck cancer surgical patients were enrolled. 59% of the patients used the nutritional supplement, 41% did not. Of the 80 patients who did not receive the immunonutrition formula, 38 (47.5%) experienced post-operative complications of all types as compared to 29 of the 115 (25.2%) patients who did consume the product (p = 0.0021). Pharyngeal leaks or fistulas were the most common post-operative complications in both groups and more common in patients who did not receive supplementation (p = 0.007). Length of stay was on average 2.8 days longer in patients who did not have enhanced nutrition (p = 0.02), while readmission rates between the two groups were similar (p = 0.91). Measurements of nutritional biomarkers were not reported secondary to low collection rates. Conclusion Enhanced perioperative nutrition may result in significant reductions of post-operative fistula formations and decreased length of stay in a high-risk head and neck cancer population, even in the setting of poor compliance. The potential quality improvement in both patient care and healthcare cost is both real and significant.

AB - Objectives Investigate both the utility and feasibility of perioperative nutritional supplementation with an arginine-enriched immunonutrition formula to high-risk head and neck cancer surgical patients and examine its effects on acute post-operative clinical outcomes. Materials & Methods This prospective, non-randomized, interventional cohort study compared high-risk head and neck cancer surgical patients who consumed a pre- and post-operative arginine-based nutritional supplement to those that did not. Outcome measures included post-operative complications, length of hospitalization, readmission rates and measurement of nutritional biomarkers. Results 195 high-risk head and neck cancer surgical patients were enrolled. 59% of the patients used the nutritional supplement, 41% did not. Of the 80 patients who did not receive the immunonutrition formula, 38 (47.5%) experienced post-operative complications of all types as compared to 29 of the 115 (25.2%) patients who did consume the product (p = 0.0021). Pharyngeal leaks or fistulas were the most common post-operative complications in both groups and more common in patients who did not receive supplementation (p = 0.007). Length of stay was on average 2.8 days longer in patients who did not have enhanced nutrition (p = 0.02), while readmission rates between the two groups were similar (p = 0.91). Measurements of nutritional biomarkers were not reported secondary to low collection rates. Conclusion Enhanced perioperative nutrition may result in significant reductions of post-operative fistula formations and decreased length of stay in a high-risk head and neck cancer population, even in the setting of poor compliance. The potential quality improvement in both patient care and healthcare cost is both real and significant.

KW - Arginine

KW - Fistula

KW - Head and neck cancer

KW - Healthcare costs

KW - Laryngeal cancer

KW - Length of stay

KW - Nutritional status

KW - Oral cancer

KW - Oropharyngeal cancer

KW - Quality improvement

UR - http://www.scopus.com/inward/record.url?scp=84960471121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960471121&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2016.01.006

DO - 10.1016/j.oraloncology.2016.01.006

M3 - Article

C2 - 26803343

AN - SCOPUS:84960471121

VL - 54

SP - 42

EP - 46

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

ER -